Hiroaki Ono, Mr
Otsuka Pharmaceutical Co., Ltd.
7
0
7
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Leighton Y. Huey, MD
UConn Health
Shared therapeutic areas:
Azfar Malik, MD
Psych Care Consultants Research
Shared therapeutic areas:
Thomas Schwartz, MD
SUNY UMU at Syracuse
Shared therapeutic areas:
Anthony Rothschild, MD
University of Massachusetts, Worcester
Shared therapeutic areas:
Xinghua Gao
First Hospital of China Medical University
Shared therapeutic areas:
Mark George, MD
Medical University of South Carolina
Shared therapeutic areas:
Yair bAR-hAIM, PhD
Tel Aviv University
Shared therapeutic areas:
David Berk, MD
Arcutis Biotherapeutics, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects
Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects
Study of OPA-15406 Ointment in Patients With Atopic Dermatitis
Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects
All 7 trials loaded